Harald Erwin Vonkeman

Professor

University of Twente

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (6)

Annette van der Helm - van Mil

Full Professor

Erasmus MC

NETHERLANDS

View details

Polina Putrik

MONASH UNIVERSITY

AUSTRALIA

View details

Casper Webers

Maastricht University Medical Centre

NETHERLANDS

View details

Jorge Simões

University of Twente

NETHERLANDS

View details

Peter ten Klooster

Assistant Professor

University of Twente

NETHERLANDS

View details

Mark Bakker

Assistant Professor

University of Maastricht

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Harald Erwin Vonkeman

Research Interests

Explore related searches

Contact this professor

Articles (18)

Responsiveness and sensitivity of PROMs to change in disease activity status in early and established rheumatoid arthritis

Limited content overlap between commonly used self-report instruments for central (pain) sensitization in rheumatology

Quantification of longitudinal patient-reported burden of adverse drug reactions attributed to the use of TNF-α inhibitors in inflammatory rheumatic diseases: an observational prospective cohort study

Multimodal imaging of structural damage and inflammation in psoriatic arthritis: a comparison of DMARD-naive and DMARD-failure patients

The burden of adverse drug reactions reported by patients in the Dutch ADR monitor: a proof of concept

Impact of adverse drug reactions on the treatment pathways of early rheumatoid arthritis patients: a prospective observational cohort study

First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanercept

The impact of health literacy: associations with disease activity and medication prescription in patients with rheumatoid arthritis

Factors Associated With Residual Disease in Axial Spondyloarthritis: Results From a Clinical Practice Registry

Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases

Patients’ and health-care professionals’ perspectives on adverse drug reaction burden attributed to the use of biological DMARDs: a qualitative study

Analysis and visualization of the course and burden over time of adverse drug reactions (ADRs) attributed to TNFα-inhibitors in patients with inflammatory rheumatic diseases (IRDs)

Disease-specific ADRs of TNF-α inhibitors as reported by patients with inflammatory rheumatic diseases: a registry-based prospective multicenter cohort study

Factors associated with treatment intensification in patients with axial spondyloarthritis and high disease activity in clinical practice

Test–Retest Reliability of the Generalized Pain Questionnaire in Patients with Rheumatoid Arthritis and Preliminary Reference Values for Non-Clinical and Several Clinical Samples

Further evaluation of inflammatory and non-inflammatory aspects of pain in rheumatoid arthritis patients

Exploring discordance between Health Literacy Questionnaire scores of people with RMDs and assessment by treating health professionals

Continuous effectiveness and safety after a hospital‐wide switch to adalimumab biosimilar: An observational study in rheumatoid arthritis patients

Collaborators (6)

Annette van der Helm - van Mil

Polina Putrik

Casper Webers

Jorge Simões

Peter ten Klooster

Mark Bakker

Make your next move.